The economic impact of 5-HT3 receptor antagonists.
Cunningham
K
K
Hirsch
J
J
Freeman
A
A
D003362:Cost-Benefit Analysis; D006801:Humans; D012702:Serotonin Antagonists / Q000191:economics*; D014839:Vomiting / Q000517:prevention & control
D012702:Serotonin Antagonists